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ADVERSE CEREBRAL OUTCOMES AFTER CORONARY BYPASS SURGERY
GARY W. ROACH, M.D., MARC KANCHUGER, M.D., CHRISTINA MORA MANGANO, M.D., MARK NEWMAN, M.D.,
NANCY NUSSMEIER, M.D., RICHARD WOLMAN, M.D., ANIL AGGARWAL, M.D., KATHERINE MARSCHALL, M.D.,
STEVEN H. GRAHAM, M.D., PH.D., CATHERINE LEY, PH.D., GERARD OZANNE, M.D., AND DENNIS T. MANGANO, PH.D., M.D.,
FOR THE MULTICENTER STUDY OF PERIOPERATIVE ISCHEMIA RESEARCH GROUP
AND THE ISCHEMIA RESEARCH AND EDUCATION FOUNDATION INVESTIGATORS*

ABSTRACT
Background Acute changes in cerebral function
after elective coronary bypass surgery are a difficult
clinical problem. We carried out a multicenter study
to determine the incidence and predictors of — and
the use of resources associated with — perioperative
adverse neurologic events, including cerebral injury.
Methods In a prospective study, we evaluated 2108
patients from 24 U.S. institutions for two general categories of neurologic outcome: type I (focal injury, or
stupor or coma at discharge) and type II (deterioration
in intellectual function, memory deficit, or seizures).
Results Adverse cerebral outcomes occurred in
129 patients (6.1 percent). A total of 3.1 percent had
type I neurologic outcomes (8 died of cerebral injury,
55 had nonfatal strokes, 2 had transient ischemic attacks, and 1 had stupor), and 3.0 percent had type II
outcomes (55 had deterioration of intellectual function and 8 had seizures). Patients with adverse cerebral outcomes had higher in-hospital mortality (21
percent of patients with type I outcomes died, vs. 10
percent of those with type II and 2 percent of those
with no adverse cerebral outcome; P0.001 for all
comparisons), longer hospitalization (25 days with
type I outcomes, 21 days with type II, and 10 days
with no adverse outcome; P0.001), and a higher
rate of discharge to facilities for intermediate- or
long-term care (47 percent, 30 percent, and 8 percent;
P0.001). Predictors of type I outcomes were proximal aortic atherosclerosis, a history of neurologic
disease, and older age; predictors of type II outcomes
were older age, systolic hypertension on admission,
pulmonary disease, and excessive consumption of
alcohol.
Conclusions Adverse cerebral outcomes after coronary bypass surgery are relatively common and serious; they are associated with substantial increases
in mortality, length of hospitalization, and use of intermediate- or long-term care facilities. New diagnostic and therapeutic strategies must be developed to
lessen such injury. (N Engl J Med 1996;335:1857-63.)
©1996, Massachusetts Medical Society.

S

TROKE, the third leading cause of death
in the United States, will continue to be a
challenging problem as the population ages.
Patients who undergo myocardial revascularization procedures, now more than 800,000 a year
throughout the world, are particularly prone to
stroke, encephalopathy, and other neurologic dysfunction, because they are relatively old and have atherosclerotic disease. They are also subject to marked
hemodynamic fluctuations; cerebral embolization of
atherosclerotic plaque, air, fat, and platelet aggregates; cerebral hyperthermia after the discontinuation of cardiopulmonary bypass; and other inflammatory and neurohumoral derangements associated
with surgery.1-5
Although cerebral complications are responsible
for an increasing proportion of perioperative deaths,6,7
their incidence and effects have not been rigorously
investigated. The majority of studies have been performed only at one center, have enrolled a limited
number of patients, or have been retrospective (all of
which has resulted in substantial variability among
findings). Among the studies, for example, there is a
more than 10-fold variation in the reported incidence
of perioperative stroke (from 0.4 to 5.4 percent) and
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a 3-fold variation (25 to 79 percent) in that of inhospital neuropsychological dysfunction.3,4,8,9 Studies
of perioperative stroke have not attempted to identify
potentially reversible risk factors, nor have they examined the long-term impact of perioperative cerebral
outcomes on the use of resources.3,7,10
Our investigation was designed as a multi-institutional, prospective, observational study to determine
the incidence of both stroke and encephalopathy after coronary-artery bypass graft (CABG) surgery, to
identify the independent predictors of these cerebral
outcomes, and to define their impact on the use of
resources, as measured by the lengths of hospital
stays and the need for intensive intermediate- or
long-term care.
METHODS
The cardiac surgery study of the Multicenter Study of Perioperative Ischemia was a prospective observational study that enrolled
2417 patients who underwent elective CABG surgery in 24 U.S.
medical institutions between September 1991 and September
1993. The goals of the study were to define the incidence of adverse perioperative outcomes, to measure the prevalence of selected characteristics of the patients, and to assess the use of resources.
At each of the centers, between 100 and 108 patients were prospectively enrolled according to a systematic sampling scheme, and
perioperative demographic, clinical, and laboratory data were collected on the patients from hospital entry to discharge. Data on
all patients with new perioperative neurologic findings were independently reviewed by six investigators, who examined additional
data (computed-tomography findings, autopsy reports, and hospital-discharge summaries) if necessary. Final classification of outcome was made by consensus of this panel in two categories: type
I was defined as death due to stroke or hypoxic encephalopathy,
nonfatal stroke, transient ischemic attack (TIA), or stupor or coma
at the time of discharge; and type II was defined as a new deterioration in intellectual function, confusion, agitation, disorientation, memory deficit, or seizure without evidence of focal injury.
Because the two types of neurologic outcome were assumed to
have different causes and predictors, and because the predictors for
type I outcome could potentially mask those for type II, patients
with more than one type of neurologic outcome were classified,
for analytic purposes, hierarchically, according to the severity of
outcome. Type I outcomes were considered more severe than type
II. Within type I, the diagnoses were ranked from most to least
severe: fatal injury, stroke, stupor or coma, and TIA. The type II
diagnoses were ranked in a similar fashion.
Patients excluded from the analysis (n  309) could not be evaluated for neurologic outcome (6 patients), had undergone concomitant intracardiac or vascular procedures (299 patients), or had
died during surgery (4 patients) (none died of cerebral causes).
Variables considered potential predictors of neurologic outcome
were categorized according to operative stage as preoperative (e.g.,
age, sex, a history of congestive heart failure or of CABG), intraoperative (e.g., the duration of cardiopulmonary bypass and aortic
cross-clamping, surgical and anesthetic technique, hemodynamic
changes, the use of transfusions), and postoperative (e.g., myocardial infarction, dysrhythmia, ventricular dysfunction). The use of
resources was assessed on the basis of (1) the length of stay in the
intensive care unit and the total postsurgical stay in the hospital,
and (2) the site to which the patient was discharged (his or her
home or an intermediate- or long-term care facility).
Statistical Analysis
The univariable associations between adverse neurologic outcome (type I or type II) and potential predictors were assessed
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with either Fisher’s exact test or the Kruskal–Wallis test, as appropriate. Stepwise logistic regression was then performed separately
for type I and type II outcomes, including predictors associated
with P values no greater than 0.20 in univariable analyses and
keeping predictors with P values no greater than 0.15 in the multivariable model. All models were sorted with Akaike’s information criterion (AIC)11; goodness of fit for each model was determined with the Hosmer–Lemeshow test.12 The model with the
lowest AIC was considered to have the best fit.
The data in this study produced several models with similar low
AIC values. Our final model was chosen on the basis of clinical
relevance, and not all variables reached a P value of 0.05 or less.
Results are reported as odds ratios with associated 95 percent
confidence intervals.

RESULTS

Demographic and operative characteristics of the
2108 patients in this study are presented in Table 1.
Patients were relatively old (32 percent were 70 years
of age or more) and had a history of hypertension,
unstable angina, heart failure, or diabetes; approximately 8 percent had a history of stroke or transient
ischemic attack. A total of 6.1 percent of the patients
(129) had perioperative adverse cerebral outcomes.
Type I outcomes occurred in 3.1 percent (66), including 8 deaths due to cerebral injury, 55 nonfatal
strokes, 2 TIAs, and 1 case of stupor at the time of
discharge. Type II outcomes occurred in 3.0 percent
(63), including 55 with deterioration in intellectual
function and 8 with seizures. The outcome rates, according to institution, ranged from 1 percent to 13.8
percent (range for type I outcomes alone, 0 to 8.6
percent; for type II, 0 to 9.3 percent).
Predictors of Type I and Type II Outcomes

On the basis of our univariable analysis (Table 1),
logistic regression identified eight independent predictors of type I cerebral outcomes (Table 2). Proximal aortic atherosclerosis, as identified by the cardiac
surgeon, was the strongest independent predictor, associated with a more than fourfold increase in risk. It
was followed by a history of neurologic disease, an
age of 70 or more (Fig. 1), and a history of pulmonary disease. Both perioperative hypotension and the
use of a ventricular venting procedure during surgery, although their point estimates were not statistically significant, were included in the final model
since they did not detract from the statistical fit of
the model and they have clinical relevance. Adjustment for the study site did not affect the results of
the multivariable model. Ten independent predictors
of type II cerebral outcome were identified, of which
seven were statistically significant (P0.05) (Table
2). Predictors unique to type II were a history of excessive alcohol consumption, prior CABG surgery,
dysrhythmia, a history of peripheral vascular disease,
and congestive heart failure on the day of surgery (although the last two were not statistically significant).
Predictors common to both type I and type II outcomes were older age, a history of pulmonary dis-
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TABLE 1. SELECTED DEMOGRAPHIC, MEDICAL,

CHARACTERISTIC

AND

PREVALENCE OF
CHARACTERISTIC
ALL PATIENTS

OPERATIVE CHARACTERISTICS

INCIDENCE OF
TYPE I OUTCOME

IN

OF

THE STUDY PATIENTS.

INCIDENCE OF
TYPE II OUTCOME

IN PATIENTS

IN PATIENTS

IN PATIENTS

WITH

WITHOUT

WITH

IN PATIENTS
WITHOUT

CHARACTERISTIC

CHARACTERISTIC

CHARACTERISTIC

CHARACTERISTIC

percent

Age 70 yr
Medical history*
Neurologic disease
Carotid disease
Valve disease
Dysrhythmia
Unstable angina
CABG
Peripheral vascular disease
Congestive heart failure
Myocardial infarction
Diabetes mellitus
Pulmonary disease
Excessive alcohol consumption
Hypertension
Preoperative factors
Systolic blood pressure
180 mm Hg
Antihypertensive therapy
Intraoperative factors
Proximal aortic atherosclerosis
Intraoperative hypotension
Use of intraaortic balloon pump
Ventricular or atrial venting
Postoperative factors†
Congestive heart failure
Dysrhythmia

31.9

6.1

1.9

5.8

1.8

8.3
14.7
19.9
11.3
47.7
12.9
13.8
26.4
55.4
25.1
17.5
9.8
57.2

10.1
7.8
6.14
3.6
4.4
6.2
6.5
4.9
3.9
5.5
6.1
5.6
4.5

2.5
2.5
1.3
3.2
2.2
2.8
2.7
2.6
2.2
2.4
2.7
3.0
1.6

4.7
4.5
4.6
5.7
3.7
5.5
5.9
4.9
3.2
3.4
6.3
5.6
3.3

2.9
2.8
2.1
2.8
2.4
2.7
2.7
2.4
3.0
3.0
2.4
2.8
2.4

2.9

11.0

3.0

12.5

2.8

20.7

4.6

2.9

5.7

2.4

12.4
10.6
7.6
76.3

11.2
6.2
9.0
3.6

2.1
2.9
2.8
1.9

5.2
6.2
4.1
3.4

2.8
2.7
3.0
2.1

2.6
18.0

10.2
3.6

3.1
3.1

10.2
5.7

2.9
2.5

*History of carotid disease includes carotid bruit, stenosis, and carotid endarterectomy. Excessive alcohol consumption
indicates hospitalization because of alcohol consumption or alcohol withdrawal. CABG denotes coronary-artery bypass
graft.
†These conditions were assessed in the intensive care unit immediately after surgery.

ease, a history of hypertension or existing hypertension, and perioperative hypotension.
Postoperative Course

Type I outcomes were associated with an approximately 10-fold increase in in-hospital mortality, and
type II with an approximately 5-fold increase (Table
3). Similarly, the average length of the postsurgical
hospital stay and the amount of time spent in intensive care were at least doubled in the patients with
adverse cerebral outcomes. Of the patients with type
I outcomes, 47 percent were discharged to skillednursing facilities or rehabilitation centers, as compared with 30 percent of patients with type II outcomes and 8 percent of patients without adverse
cerebral outcomes.
DISCUSSION

This study was a large multicenter, prospective
investigation of adverse cerebral outcomes after elective CABG surgery. Serious adverse cerebral outcomes occurred in 6.1 percent of patients, evenly di-

vided between type I outcomes (fatal cerebral injury
and nonfatal strokes) and type II (new deterioration
in intellectual function or new onset of seizures).
Adverse cerebral outcomes were associated with significantly increased mortality and use of medical resources. There was a 5-to-10-fold increase in mortality associated with type I and type II outcomes;
furthermore, the 21 percent mortality rate found
with perioperative stroke is similar to the rate reported from a single center more than a decade ago and
suggests that stroke-related mortality has not decreased over the past decade.6 The duration of intensive care and of the total hospital stay was prolonged
by both type I and type II outcomes — a finding not
previously reported with type II outcomes. High-risk
characteristics were identified; they included, among
others, advanced age, proximal aortic atherosclerosis,
neurologic disease, pulmonary disease, and a history
of or existing hypertension. These results emphasize
the medical importance of adverse cerebral outcomes
after CABG surgery; they have economic implications as well.1,3,13
Vo l u m e 3 3 5
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TABLE 2. ADJUSTED ODDS RATIOS FOR TYPE I AND TYPE II CEREBRAL OUTCOMES
ASSOCIATED WITH SELECTED RISK FACTORS.*

FACTOR

MODEL FOR TYPE I
CEREBRAL OUTCOME

MODEL FOR TYPE II
CEREBRAL OUTCOME

odds ratio (95% confidence interval)

Significant factors (P0.05)
Proximal aortic atherosclerosis
History of neurologic disease
Use of intraaortic balloon pump
Diabetes mellitus
History of hypertension
History of pulmonary disease
History of unstable angina
Age (per additional decade)
Systolic blood pressure 180 mm Hg at admission
History of excessive alcohol consumption
History of CABG
Dysrhythmia on day of surgery
Antihypertensive therapy
Other factors (P not significant)†
Perioperative hypotension
Ventricular venting
Congestive heart failure on day of surgery
History of peripheral vascular disease

4.52
3.19
2.60
2.59
2.31
2.09
1.83
1.75

(2.52–8.09)
(1.65–6.15)
(1.21–5.58)
(1.46–4.60)
(1.20–4.47)
(1.14–3.85)
(1.03–3.27)
(1.27–2.43)

1.92 (0.93–3.97)
1.83 (0.86–3.90)

2.37 (1.34–4.18)
2.20
3.47
2.64
2.18
1.97
1.78

(1.60–3.02)
(1.41–8.55)
(1.27–5.47)
(1.14–4.17)
(1.12–3.46)
(1.02–3.10)

1.88 (0.97–3.65)
2.46 (0.85–7.09)
1.64 (0.89–3.04)

*Odds ratios are for the risk of a type I or II outcome in patients with the risk factor in question
as compared with those without the risk factor. Odds ratios have been adjusted for all the factors
listed for each model. Excessive alcohol consumption indicates hospitalization because of alcohol
consumption or alcohol withdrawal. Perioperative hypotension indicates a systolic blood pressure
80 mm Hg (during surgery but before cardiopulmonary bypass, or after bypass) or 40 mm Hg
(during bypass) for more than 10 minutes. CABG denotes coronary-artery bypass graft.
†In addition to factors from Table 1, the following characteristics, studied in univariable analysis,
did not remain in the model: sex, aortic cross-clamping, duration of cardiopulmonary bypass and
surgery, and institution.

We examined conservative measures of resource
use — namely, the duration of intensive care, the total duration of the hospital stay after surgery, and
the rate of discharge to intermediate- or long-term
care facilities. All three measures were markedly prolonged for patients with either type I or type II adverse neurologic outcomes. As compared with patients without adverse cerebral outcomes, patients
with stroke stayed an additional eight days in the
intensive care unit and an additional seven days on
the ward, suggesting that regardless of institutional
practice, substantial resources are consumed by such
patients. This confirms previous findings from single-center studies.2,4,10,14 Again as compared with patients without adverse cerebral outcomes, patients
with type II outcomes stayed an additional four days
in the intensive care unit and seven days on the
ward. On the basis of conservative estimates of boarding charges of $890 per day in an intensive care unit
and $370 per day on a ward,1,14 type I neurologic
events are responsible for an additional $10,266 per
patient in in-hospital boarding costs, and type II
events for an additional $6,150 per patient.1-3,10,14 If
we apply these estimates to the 800,000 patients per
1860 

year who undergo CABG surgery throughout the
world, the additional in-hospital cost is approximately $400 million annually.1 True in-hospital costs, including charges for personnel and in-hospital services, if added to the expense of an array of long-term
out-of-hospital medical and rehabilitative services,
probably result in an additional expenditure ranging
from 5 to 10 times the narrowly defined in-hospital
costs, or some $2 billion to $4 billion annually.1 As
an example of the increased cost, consider that 90
percent of patients without adverse cerebral outcomes were discharged to their homes, as compared
with only 32 percent of patients with type I outcomes
and 60 percent with type II outcomes. Whether the
need for prolonged hospitalization and the changes
in discharge patterns are caused directly by the neurologic complications or by other associated illness
is uncertain, yet it is likely that adverse cerebral outcomes affect the use of health care resources profoundly.
Predictors Unique to Type I Outcomes

Moderate-to-severe proximal aortic atherosclerosis, as identified by intraoperative palpation of the
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Figure 1. Incidence of Type I and Type II Cerebral Outcomes According to Age.

TABLE 3. MORTALITY AND POSTOPERATIVE RESOURCE USE,
ACCORDING TO CEREBRAL OUTCOME.*

VARIABLE

TYPE I
OUTCOME
(N66)

Death during hospitalization — 14 (21)
no. (%)
Duration of postoperative hospital stay — days
Mean SD
25.322.2
Median
17.6
Duration of ICU stay — days
Mean SD
11.115.4
Median
5.8
Discharged to home — no. (%)† 21 (32)

TYPE II
OUTCOME
(N63)

NO ADVERSE
CEREBRAL EVENT
(N1979)

6 (10)

38 (2)

20.525.2
10.9

9.512.4
7.7

6.67.9
3.2
38 (60)

2.63.5
1.9
1773 (90)

*P0.001 for all comparisons among the groups. ICU denotes intensive
care unit.
†Patients not discharged to their homes either died or were discharged
to intermediate- or long-term care facilities.

aorta, was associated with an incidence of type I adverse cerebral outcomes at least four times that
among patients without the condition. This finding
supports the theory that most strokes are caused by
large atherosclerotic emboli liberated by surgical
manipulation of the aorta.3,15-22 In our study, proximal aortic atherosclerosis, detected by palpation, was
found in approximately 12 percent of all patients
and in 20 percent of patients 70 years of age.
Moderate or severe atherosclerotic disease has been
detected with ultrasonographic scanning in 14 to 20
percent of elderly patients.3,23-27 Although palpation
of the aorta is not as sensitive a measure as other
techniques, such as echocardiography, the method is
simple and can be used routinely to identify patients
at risk and therefore to indicate alterations in surgical technique. Such alterations might include the adjustment of the site for aortic clamping and cannulation, to avoid atherosclerotic regions; the use of
arterial conduits (e.g., internal thoracic or epigastric

arteries) to avoid aortic anastomoses; the use of hypothermic fibrillatory arrest without clamping the
aorta; or the use of hypothermic circulatory arrest,
with replacement of the diseased aorta.1,3,4,24,27-30
A history of neurologic abnormality — for example, stroke or TIA — was also a significant risk factor
for type I outcomes, a finding consistent with those
of other studies.7,31 A history of neurologic disease
suggests existing pathologic cerebrovascular conditions, such as impaired cerebral blood flow and autoregulation or inadequate collateral vessels, which
may predispose patients to a type I cerebral complication after CABG surgery. Patients with diabetes
mellitus also had an increased risk of a type I outcome, perhaps reflecting these patients’ impaired
autoregulation during bypass3,4,15,32 or more generalized atherosclerosis, involving the aorta or the
carotid or cerebral arteries. Unstable angina has been
associated with a prothrombotic state and systemic
immunologic-cascade activation that may contribute
to the development of neurologic injury.33 The use
of a left ventricular venting procedure was weakly associated with the occurrence of a type I adverse neurologic outcome, but the relatively small number of
patients without vents limited statistical assessment.
The placement of a vent may introduce air into the
left side of the heart that subsequently embolizes
and travels to the brain3,4,19,34 — a danger that highlights the importance of fastidious surgical technique if a vent is used. A final factor, the use of an
intraaortic balloon pump, may be associated with
the dislodgment of aortic emboli or may be a marker of hypoperfusion.
Predictors Unique to Type II Outcomes

Proximal aortic atherosclerosis was not an independent predictor of type II cerebral outcomes,
suggesting that large atherosclerotic emboli do not
have a primary role in the pathophysiology of encephalopathy or seizures after bypass surgery. This is
consistent with previous studies demonstrating an
association between small emboli, or inadequate
cerebral flow, and type II outcomes.1,3,4,35,36 Risk
factors unique to type II outcomes were a history of
excessive alcohol consumption; postoperative dysrhythmia (mainly, atrial fibrillation), which may induce cerebral emboli or hypoperfusion14; and a history of CABG or peripheral vascular disease, which
may reflect more advanced atherosclerosis.
Predictors of Both Type I and Type II Outcomes

Advanced age, particularly an age of 70 or more,
was a leading factor associated with both type I and
type II adverse cerebral outcomes. Aging is associated with atherosclerosis and an increased risk of embolic phenomena, as well as with alterations in cerebral vasculature3,4,6,7,15,17,37-40 and the autoregulation
of blood flow,8,41-43 all of which may increase the inVo l u m e 3 3 5
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cidence of perioperative stroke, cognitive dysfunction, and delirium.3,4,6,7,15,18,28,38-40,44,45 Pulmonary
disease (emphysema, chronic bronchitis, restrictive
lung disease, or asthma), a previously unreported
risk factor for either type I or type II outcomes,
was in our study a significant predictor of both; patients with pulmonary disease probably retained
carbon dioxide (thus affecting cerebral vasoreactivity) or required prolonged mechanical ventilation
(thus affecting the degree of cerebral perfusion and
oxygenation).1,3,16,28,46 Both a history of hypertension and existing hypertension were associated with
adverse cerebral outcomes — a reflection of impaired cerebrovascular autoregulation and more
generalized atherosclerotic disease in hypertensive
patients.
Strengths and Limitations of the Study

The reported incidence of perioperative stroke in
studies from only one center varies by a factor of
more than 10, from 0.4 to 5.4 percent,1-4,8,16,47 with
similar variability in the rates of encephalopathy, delirium, and confusion. Most likely, this variability is
due to differences in study design (for instance,
whether the studies were retrospective or prospective), methods, sample size, and the effects of sitespecific factors.1-3,9,48,49 Our study addressed these
limitations by enrolling patients at multiple diverse
institutions, thereby minimizing distortion due to
the effects of surgical, anesthetic, perfusion-related,
and medical practices specific to a single center; randomizing enrollment and limiting it to a period of
24 months in order to decrease the impact of temporal changes in practice; collecting data prospectively; and excluding procedures, such as valve replacement or aneurysmectomy, that might increase
a patient’s risk of adverse neurologic events.4,20,31
Our study, however, has several limitations of its
own. First, the neurologic findings were assessed by
investigators at each site, not by a single neurologist
performing all preoperative and postoperative examinations; there may be significant variations in clinical practice, and thus diagnosis, among the 24 centers (although no site-related effect was identified).
Second, neuropsychological deficits were not formally assessed because of several constraints, including a lack of technical experience in neuropsychological testing and the time required for such
testing. Our assessment of deterioration in intellectual function is thus open to criticism. Third, our
categorization of outcomes as type I or type II presumed differences in the characteristic mechanisms
of injury in the two types — focal and diffuse,
respectively35,36 (although this presumption is consistent with our finding that few of the predictors in
the multivariable analysis of type I and type II outcomes were similar). Fourth, we detected aortic atherosclerosis by surgical palpation. Recent studies
1862 

have shown that ultrasonography is superior to palpation in detecting aortic atheromas, but our study
was designed and our data collected before the publication of those reports. Finally, several recent studies
suggest an association between the presence of carotid-artery stenosis, as documented by carotid duplex
scanning, and stroke after cardiac surgery.1,3,4,24,31 We
found a strong univariable correlation between the
presence of carotid disease (including carotid bruit,
stenosis, or endarterectomy) and type I cerebral outcomes (P0.001), but carotid duplex scanning was
not performed as part of the study. Perhaps because
of the relatively poor specificity and selectivity of carotid bruit as a sign of hemodynamically important
lesions, we were unable to document an association
between carotid disease and adverse cerebral outcome in the multivariable analysis.
On the basis of data from 24 U.S. medical centers,
we conclude that adverse perioperative cerebral outcomes are both relatively common (they occur in 6.1
percent of patients) and serious. As compared with
patients with no adverse outcomes, the patients with
such outcomes had 5 to 10 times the mortality, 2 to
4 times the time spent in intensive care and in the
hospital, and 3 to 6 times the need for prolonged
care. We were able to identify patients at high risk
both for focal and for diffuse injury, thereby allowing improved stratification of risk. Further investigation is necessary, however, to develop diagnostic and
therapeutic strategies1,3,49 to reduce mortality and
morbidity and to conserve resources.
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